International Biotechnology Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $6.52M | Sell |
36,800
-44,800
| -55% | -$7.93M | 2.2% | 18 |
|
|
2023
Q2 | $15.5M | Buy |
81,600
+35,000
| +75% | +$6.65M | 4.72% | 7 |
|
|
2023
Q1 | $9.33M | Buy |
46,600
+8,600
| +23% | +$1.72M | 2.6% | 12 |
|
|
2022
Q4 | $9.02M | Hold |
38,000
| – | – | 2.79% | 11 |
|
|
2022
Q3 | $7.6M | Buy |
38,000
+32,458
| +586% | +$6.49M | 2.44% | 14 |
|
|
2022
Q2 | $38K | Sell |
5,542
-32,458
| -85% | -$223K | 0.4% | 50 |
|
|
2022
Q1 | $21.7M | Sell |
38,000
-90,000
| -70% | -$51.4M | 4.9% | 3 |
|
|
2021
Q4 | $21.7M | Buy |
128,000
+53,000
| +71% | +$8.99M | 4.84% | 3 |
|
|
2021
Q3 | $14.2M | Sell |
75,000
-74,000
| -50% | -$14M | 3.42% | 10 |
|
|
2021
Q2 | $25.2M | Buy |
149,000
+40,200
| +37% | +$6.81M | 6.66% | 2 |
|
|
2021
Q1 | $15.4M | Buy |
108,800
+72,500
| +200% | +$10.2M | 4.06% | 9 |
|
|
2020
Q4 | $4.72M | Hold |
36,300
| – | – | 1.29% | 21 |
|
|
2020
Q3 | $5.28M | Hold |
36,300
| – | – | 1.7% | 19 |
|
|
2020
Q2 | $5.37M | Buy |
36,300
+14,000
| +63% | +$2.07M | 1.79% | 20 |
|
|
2020
Q1 | $2.43M | Sell |
22,300
-21,000
| -48% | -$2.28M | 1.11% | 21 |
|
|
2019
Q4 | $4.99M | Buy |
43,300
+9,500
| +28% | +$1.09M | 1.8% | 20 |
|
|
2019
Q3 | $2.72M | Hold |
33,800
| – | – | 1.25% | 20 |
|
|
2019
Q2 | $2.45M | Hold |
33,800
| – | – | 0.91% | 29 |
|
|
2019
Q1 | $3.16M | Hold |
33,800
| – | – | 1.17% | 29 |
|
|
2018
Q4 | $1.94M | Sell |
33,800
-19,000
| -36% | -$1.09M | 1.2% | 24 |
|
|
2018
Q3 | $3.54M | Buy |
52,800
+16,000
| +43% | +$1.07M | 1.68% | 21 |
|
|
2018
Q2 | $3.62M | Hold |
36,800
| – | – | 1.39% | 24 |
|
|
2018
Q1 | $4.38M | Hold |
36,800
| – | – | 1.71% | 19 |
|
|
2017
Q4 | $4.68M | Sell |
36,800
-4,500
| -11% | -$572K | 1.65% | 22 |
|
|
2017
Q3 | $4.85M | Buy |
+41,300
| New | +$4.85M | 1.89% | 18 |
|